DrArjun Muralidharan

Ph.D. (Neuropharmacology)

Dr Muralidharan completed his PhD from the laboratory of Professor Maree T. Smith at The University of Queensland in 2013. Subsequently, he then undertook his first postdoctoral tenure at the Centre for Integrated Preclinical Drug Development (CIPDD; UQ) funded by a Large ARC Linkage Grant in collaboration with Boehringer Ingelheim GmbH. In 2015, he was awarded the Ronald Melzack Fellowship in Chronic Pain to pursue his second postdoctoral tenure in the Pain Genetics laboratory of Professor Jeffrey S. Mogil at McGill University (Canada). He is now the Group Leader of the Neurobiology of Chronic Pain Research lab at SOLES. To date, Dr Muralidharan has received >$2M in research funding. Currently, supported by NHMRC Ideas Grant, his research work focuses on molecular dissection of the interplay between chronic pain and ageing, and developing a stem-cell based analgesic therapy for the treatment of chronic pain.